Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ekso Bionics Holdings (EKSO) Other Accumulated Expenses (2016 - 2025)

Historic Other Accumulated Expenses for Ekso Bionics Holdings (EKSO) over the last 7 years, with Q3 2025 value amounting to $244000.0.

  • Ekso Bionics Holdings' Other Accumulated Expenses rose 10677.97% to $244000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $244000.0, marking a year-over-year increase of 10677.97%. This contributed to the annual value of $194000.0 for FY2024, which is 3379.31% up from last year.
  • Latest data reveals that Ekso Bionics Holdings reported Other Accumulated Expenses of $244000.0 as of Q3 2025, which was up 10677.97% from $153000.0 recorded in Q2 2025.
  • In the past 5 years, Ekso Bionics Holdings' Other Accumulated Expenses registered a high of $256000.0 during Q2 2023, and its lowest value of $97000.0 during Q2 2024.
  • Its 4-year average for Other Accumulated Expenses is $164181.8, with a median of $153000.0 in 2025.
  • As far as peak fluctuations go, Ekso Bionics Holdings' Other Accumulated Expenses tumbled by 6210.94% in 2024, and later soared by 10677.97% in 2025.
  • Over the past 4 years, Ekso Bionics Holdings' Other Accumulated Expenses (Quarter) stood at $161000.0 in 2022, then decreased by 9.94% to $145000.0 in 2023, then skyrocketed by 33.79% to $194000.0 in 2024, then increased by 25.77% to $244000.0 in 2025.
  • Its Other Accumulated Expenses was $244000.0 in Q3 2025, compared to $153000.0 in Q2 2025 and $136000.0 in Q1 2025.